Erlotinib vs Montelukast

## Erlotinib vs Montelukast: Overview

This comparison examines the pharmacological differences between **Erlotinib** and **Montelukast**.

## Mechanism of Action

**Erlotinib**: Reversible inhibitor of EGFR (HER1) tyrosine kinase, blocking autophosphorylation.

**Montelukast**: Selective leukotriene D4 receptor antagonist.

## Pharmacokinetics

**Half-life**: Erlotinib — 36 hours; Montelukast — 2.7-5.5 hours.

## Chemical Properties

**Molecular Formula**: Erlotinib — C22H23N3O4; Montelukast — C35H36ClNO3S.

**Molecular Weight**: Erlotinib — 393.4380 g/mol; Montelukast — 586.1800 g/mol.

**Type**: Erlotinib — Small molecule; Montelukast — Small molecule.